{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:29:47Z","timestamp":1790695787719,"version":"4.1.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,5,5]],"date-time":"2007-05-05T00:00:00Z","timestamp":1178323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2007,9,17]]},"DOI":"10.1007\/s11064-007-9352-7","type":"journal-article","created":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T09:44:38Z","timestamp":1178271878000},"page":"1655-1664","source":"Crossref","is-referenced-by-count":217,"title":["Myelin Breakdown and Iron Changes in Huntington\u2019s Disease: Pathogenesis and Treatment Implications"],"prefix":"10.1007","volume":"32","author":[{"given":"George","family":"Bartzokis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Tishler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia M.","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolanle","family":"Oluwadara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Paul","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Bordelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Mintz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,5]]},"reference":[{"key":"9352_CR1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"9352_CR2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1073858404266777","volume":"10","author":"SH Li","year":"2004","unstructured":"Li SH, Li XJ (2004) Huntingtin and its role in neuronal degeneration. Neuroscientist 10:467\u2013475","journal-title":"Neuroscientist"},{"key":"9352_CR3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","volume":"5","author":"C Landles","year":"2004","unstructured":"Landles C, Bates GP (2004) Huntingtin and the molecular pathogenesis of Huntington\u2019s disease. Fourth in molecular medicine review series. EMBO Rep 5:958\u2013963","journal-title":"EMBO Rep"},{"key":"9352_CR4","first-page":"241","volume-title":"Huntington\u2019s disease","author":"PS Harper","year":"1996","unstructured":"Harper PS, Shaw D (1996) Huntington\u2019s disease: genetic and molecular studies. In: Harper PS (eds) Huntington\u2019s disease 2nd edn. W.B.Saunders, Philadelphia, pp 241\u2013293","edition":"2nd edn"},{"key":"9352_CR5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/nbdi.1996.0018","volume":"3","author":"F Persichetti","year":"1996","unstructured":"Persichetti F, Carlee L, Faber PW, McNeil SM, Ambrose CM, Srinidhi J, Anderson M, Barnes GT, Gusella JF, MacDonald ME (1996) Differential expression of normal and mutant Huntington\u2019s disease gene alleles. Neurobiol Dis 3:183\u2013190","journal-title":"Neurobiol Dis"},{"key":"9352_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/archneur.56.5.569","volume":"56","author":"G Bartzokis","year":"1999","unstructured":"Bartzokis G, Cummings J, Perlman S, Hance DB, Mintz J (1999) Increased basal ganglia iron levels in Huntington disease. Arch Neurol 56:569\u2013574","journal-title":"Arch Neurol"},{"key":"9352_CR7","first-page":"151","volume-title":"Metal ions in life sciences, vol 1","author":"G Bartzokis","year":"2006","unstructured":"Bartzokis G, Lu PH, Tishler TA, Perlman S (2006) In vivo assessment of iron in Huntington\u2019s disease and other age-related degenerative brain diseases. In: Sigel A, Sigel H, Sigel RKO (eds) Metal ions in life sciences, vol 1. Wiley, Chichester, pp 151\u2013177"},{"key":"9352_CR8","first-page":"293","volume-title":"Huntington\u2019s disease, 2 edn","author":"AL Jones","year":"1996","unstructured":"Jones AL (1996) The Huntington\u2019s disease gene and its protein product. In: Harper PS (eds) Huntington\u2019s disease, 2 edn. W.B.Saunders, Philadelphia, pp 293\u2013316"},{"key":"9352_CR9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1148\/radiol.2322030820","volume":"232","author":"M Mascalchi","year":"2004","unstructured":"Mascalchi M, Lolli F, Della Nave R, Tessa C, Petralli R, Gavazzi C, Politi LS, Macucci M, Filippi M, Piacentini S (2004) Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology 232:867\u2013873","journal-title":"Radiology"},{"key":"9352_CR10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0006-3223(91)90211-4","volume":"29","author":"TL Jernigan","year":"1991","unstructured":"Jernigan TL, Salmon DP, Butters N, Hesselink JR (1991) Cerebral structure on MRI, Part II: specific changes in Alzheimer\u2019s and Huntington\u2019s diseases. Biol Psychiatry 29:68\u201381","journal-title":"Biol Psychiatry"},{"key":"9352_CR11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1212\/WNL.50.1.252","volume":"50","author":"EH Aylward","year":"1998","unstructured":"Aylward EH, Anderson NB, Bylsma FW, Wagster MV, Barta PE, Sherr M, Feeney J, Davis A, Rosenblatt A, Pearlson GD, Ross CA (1998) Frontal lobe volume in patients with Huntington\u2019s disease. Neurology. 50:252\u2013258","journal-title":"Neurology."},{"key":"9352_CR12","first-page":"553","volume":"85","author":"DM Mann","year":"1993","unstructured":"Mann DM, Oliver R, Snowden JS (1993) The topographic distribution of brain atrophy in Huntington\u2019s disease and progressive supranuclear palsy. Acta Neuropathol (Berl) 85:553\u2013559","journal-title":"Acta Neuropathol (Berl)"},{"key":"9352_CR13","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","volume":"60","author":"HD Rosas","year":"2003","unstructured":"Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Caplan K, Marek K, Seidman LJ, Makris N, Jenkins BG, Goldstein JM (2003) Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis. Neurology 60:1615\u20131620","journal-title":"Neurology"},{"key":"9352_CR14","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/brain\/awf179","volume":"125","author":"MJ Thieben","year":"2002","unstructured":"Thieben MJ, Duggins AJ, Good CD, Gomes L, Mahant N, Richards F, McCusker E, Frackowiak RS (2002) The distribution of structural neuropathology in pre-clinical Huntington\u2019s disease. Brain 125:1815\u20131828","journal-title":"Brain"},{"key":"9352_CR15","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1212\/01.WNL.0000138434.68093.67","volume":"63","author":"C Fennema-Notestine","year":"2004","unstructured":"Fennema-Notestine C, Archibald SL, Jacobson MW, Corey-Bloom J, Paulsen JS, Peavy GM, Gamst AC, Hamilton JM, Salmon DP, Jernigan TL (2004) In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 63:989\u2013995","journal-title":"Neurology"},{"key":"9352_CR16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biopsych.2005.06.003","volume":"59","author":"JS Paulsen","year":"2006","unstructured":"Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC (2006) Brain structure in preclinical Huntington\u2019s disease. Biol Psychiatry 59:57\u201363","journal-title":"Biol Psychiatry"},{"key":"9352_CR17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pscychresns.2005.05.011","volume":"140","author":"SA Reading","year":"2005","unstructured":"Reading SA, Yassa MA, Bakker A, Dziorny AC, Gourley LM, Yallapragada V, Rosenblatt A, Margolis RL, Aylward EH, Brandt J, Mori S, van Zijl P, Bassett SS, Ross CA (2005) Regional white matter change in pre-symptomatic Huntington\u2019s disease: a diffusion tensor imaging study. Psychiatry Res 140:55\u201362","journal-title":"Psychiatry Res"},{"key":"9352_CR18","first-page":"399","volume-title":"Huntington\u2019s Chorea, vol 1","author":"GW Bruyn","year":"1973","unstructured":"Bruyn GW (1973) Neuropathological changes in Huntington\u2019s chorea. In: Barbeau A, Chase TN, Paulson GW (eds) Huntington\u2019s Chorea, vol 1. Raven Press, New York, pp 399\u2013403"},{"key":"9352_CR19","first-page":"405","volume-title":"Huntington\u2019s Chorea, vol 1","author":"L Liss","year":"1973","unstructured":"Liss L, Paulson GW, Sommer A (1973) Rigid form of Huntington\u2019s chorea: a clinicopathological study of three cases. In: Barbeau A, Chase TN, Paulson GW (eds) Huntington\u2019s Chorea, vol 1. Raven Press, New York, pp 405\u2013424"},{"key":"9352_CR20","first-page":"353","volume-title":"Advances in neurology. Huntington\u2019s chorea, vol 1. 1872\u20131972","author":"GK Klintworth","year":"1973","unstructured":"Klintworth GK (1973) Huntington\u2019s chorea\u2014morphologic contributions of a century. In: Barbeau A, Paulson GW, Chase TN (eds) Advances in neurology. Huntington\u2019s chorea, vol 1. 1872\u20131972. Raven Press, New York, pp 353\u2013368"},{"key":"9352_CR21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005072-198809000-00003","volume":"47","author":"SM la Monte de","year":"1988","unstructured":"de la Monte SM, Vonsattel JP, Richardson EP Jr (1988) Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington\u2019s disease. J Neuropathol Exp Neurol 47:516\u2013525","journal-title":"J Neuropathol Exp Neurol"},{"key":"9352_CR22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/cercor\/bhh060","volume":"14","author":"A Peters","year":"2004","unstructured":"Peters A, Sethares C (2004) Oligodendrocytes, their progenitors and other neuroglial cells in the aging primate cerebral cortex. Cereb Cortex 14:995\u20131007","journal-title":"Cereb Cortex"},{"key":"9352_CR23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1212\/WNL.41.7.1117","volume":"41","author":"A Sotrel","year":"1991","unstructured":"Sotrel A, Paskevich PA, Kiely DK, Bird ED, Williams RS, Myers RH (1991) Morphometric analysis of the prefrontal cortex in Huntington\u2019s disease. Neurology 41:1117\u20131123","journal-title":"Neurology"},{"key":"9352_CR24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","volume":"50","author":"RH Myers","year":"1991","unstructured":"Myers RH, Vonsattel JP, Paskevich PA, Kiely DK, Stevens TJ, Cupples LA, Richardson EP Jr, Bird ED (1991) Decreased neuronal and increased oligodendroglial densities in Huntington\u2019s disease caudate nucleus. J Neuropathol Exp Neurol 50:729\u2013742","journal-title":"J Neuropathol Exp Neurol"},{"key":"9352_CR25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/1531-8249(200101)49:1<29::AID-ANA7>3.0.CO;2-B","volume":"49","author":"E Gomez-Tortosa","year":"2001","unstructured":"Gomez-Tortosa E, MacDonald ME, Friend JC, Taylor SA, Weiler LJ, Cupples LA, Srinidhi J, Gusella JF, Bird ED, Vonsattel JP, Myers RH (2001) Quantitative neuropathological changes in presymptomatic Huntington\u2019s disease. Ann Neurol 49:29\u201334","journal-title":"Ann Neurol"},{"key":"9352_CR26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neurobiolaging.2003.03.001","volume":"25","author":"G Bartzokis","year":"2004","unstructured":"Bartzokis G (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer\u2019s disease. Neurobiol Aging 25:5\u201318","journal-title":"Neurobiol Aging"},{"key":"9352_CR27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrn1537","volume":"5","author":"L Zecca","year":"2004","unstructured":"Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5:863\u2013873","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl 1","key":"9352_CR28","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1002\/ana.410320716","volume":"32","author":"DT Dexter","year":"1992","unstructured":"Dexter DT, Jenner P, Schapira AH, Marsden CD (1992) Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson\u2019s Disease Research Group. Ann Neurol 32(Suppl 1): S94\u2013S100","journal-title":"Ann Neurol"},{"key":"9352_CR29","first-page":"275","volume":"14","author":"JC Chen","year":"1993","unstructured":"Chen JC, Hardy PA, Kucharczyk W, Clauberg M, Joshi JG, Vourlas A, Dhar M, Henkelman RM (1993) MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am J Neuroradiol 14:275\u2013281","journal-title":"AJNR Am J Neuroradiol"},{"issue":"Suppl 1","key":"9352_CR30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000116719","volume":"31","author":"MB Youdim","year":"1991","unstructured":"Youdim MB, Ben-Shachar D, Riederer P (1991) Iron in brain function and dysfunction with emphasis on Parkinson\u2019s disease. Eur Neurol 31(Suppl 1):34\u201340","journal-title":"Eur Neurol"},{"issue":"Suppl 1","key":"9352_CR31","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1002\/ana.410320710","volume":"32","author":"JR Connor","year":"1992","unstructured":"Connor JR, Benkovic SA (1992) Iron regulation in the brain: histochemical, biochemical, and molecular considerations. Ann Neurol 32(Suppl 1):S51\u2013S61","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"9352_CR32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0022-510X(95)00206-H","volume":"134","author":"JR Connor","year":"1995","unstructured":"Connor JR, Menzies SL (1995) Cellular management of iron in the brain. J Neurol Sci 134(Suppl):33\u201344","journal-title":"J Neurol Sci"},{"key":"9352_CR33","doi-asserted-by":"crossref","unstructured":"Bartzokis G, Tishler TA, Shin I-S, Lu PH, Cummings JL (2004) Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. In: LeVine S, Connor J, Schipper H (eds) Redox-active metals in neurological disorders, vol 1012. Ann N Y Acad Sci, New York, pp 224\u2013236","DOI":"10.1196\/annals.1306.019"},{"key":"9352_CR34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/01.rmr.0000245461.90406.ad","volume":"17","author":"D Berg","year":"2006","unstructured":"Berg D, Youdim MB (2006) Role of iron in neurodegenerative disorders. Top Magn Reson Imaging 17:5\u201317","journal-title":"Top Magn Reson Imaging"},{"key":"9352_CR35","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4613-2081-4","volume-title":"Basics of magnetic resonance imaging","author":"WH Oldendorf","year":"1988","unstructured":"Oldendorf WH, Oldendorf W Jr (1988) Basics of magnetic resonance imaging. Martinus Nijhof Publishing, Boston, MA"},{"key":"9352_CR36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/mrm.1910060304","volume":"6","author":"RL Kamman","year":"1988","unstructured":"Kamman RL, Go KG, Brouwer W, Berendsen HJ (1988) Nuclear magnetic resonance relaxation in experimental brain edema: effects of water concentration, protein concentration, and temperature. Magn Reson Med 6:265\u2013274","journal-title":"Magn Reson Med"},{"key":"9352_CR37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mrm.1910290406","volume":"29","author":"G Bartzokis","year":"1993","unstructured":"Bartzokis G, Aravagiri M, Oldendorf WH, Mintz J, Marder SR (1993) Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med 29:459\u2013464","journal-title":"Magn Reson Med"},{"key":"9352_CR38","first-page":"1129","volume":"15","author":"G Bartzokis","year":"1994","unstructured":"Bartzokis G, Mintz J, Sultzer D, Marx P, Herzberg JS, Phelan CK, Marder SR (1994) In vivo MR evaluation of age-related increases in brain iron. AJNR Am J Neuroradiol 15:1129\u20131138","journal-title":"AJNR Am J Neuroradiol"},{"key":"9352_CR39","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/jmri.1880050514","volume":"5","author":"J Vymazal","year":"1995","unstructured":"Vymazal J, Hajek M, Patronas N, Giedd JN, Bulte JW, Baumgarner C, Tran V, Brooks RA (1995) The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration. J Magn Reson Imaging 5:554\u2013560","journal-title":"J Magn Reson Imaging"},{"issue":"Suppl 1","key":"9352_CR40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0022-510X(95)00204-F","volume":"134","author":"J Vymazal","year":"1995","unstructured":"Vymazal J, Brooks RA, Patronas N, Hajek M, Bulte JW, Di Chiro G (1995) Magnetic resonance imaging of brain iron in health and disease. J Neurol Sci 134(Suppl 1):19\u201326","journal-title":"J Neurol Sci"},{"key":"9352_CR41","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/00005072-199608000-00001","volume":"55","author":"A Peters","year":"1996","unstructured":"Peters A, Rosene DL, Moss MB, Kemper TL, Abraham CR, Tigges J, Albert MS (1996) Neurobiological bases of age-related cognitive decline in the rhesus monkey. J Neuropathol Exp Neurol 55:861\u2013874","journal-title":"J Neuropathol Exp Neurol"},{"key":"9352_CR42","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.neurobiolaging.2003.09.005","volume":"25","author":"G Bartzokis","year":"2004","unstructured":"Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings J (2004) Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical \u201cdisconnection\u201d in aging and Alzheimer\u2019s disease. Neurobiol Aging 25:843\u2013851","journal-title":"Neurobiol Aging"},{"key":"9352_CR43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archpsyc.63.1.63","volume":"63","author":"G Bartzokis","year":"2006","unstructured":"Bartzokis G, Lu PH, Geschwind DH, Edwards N, Mintz J, Cummings JL (2006) Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Arch Gen Psychiatry 63:63\u201372","journal-title":"Arch Gen Psychiatry"},{"key":"9352_CR44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0730-725X(96)00234-2","volume":"15","author":"G Bartzokis","year":"1997","unstructured":"Bartzokis G, Beckson M, Hance DB, Marx P, Foster JA, Marder SR (1997) MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn Reson Imaging 15:29\u201335","journal-title":"Magn Reson Imaging"},{"key":"9352_CR45","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0006-3223(94)90047-7","volume":"35","author":"G Bartzokis","year":"1994","unstructured":"Bartzokis G, Sultzer D, Mintz J, Holt LE, Marx P, Phelan CK, Marder SR (1994) In vivo evaluation of brain iron in Alzheimer\u2019s disease and normal subjects using MRI. Biol Psychiatry 35:480\u2013487","journal-title":"Biol Psychiatry"},{"key":"9352_CR46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/mrm.1910350108","volume":"35","author":"J Vymazal","year":"1996","unstructured":"Vymazal J, Brooks RA, Baumgarner C, Tran V, Katz D, Bulte JW, Bauminger R, Di Chiro G (1996) The relation between brain iron and NMR relaxation times: an in vitro study. Magn Reson Med 35:56\u201361","journal-title":"Magn Reson Med"},{"key":"9352_CR47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mrm.1910360111","volume":"36","author":"J Vymazal","year":"1996","unstructured":"Vymazal J, Zak O, Bulte JW, Aisen P, Brooks RA (1996) T1 and T2 of ferritin solutions: effect of loading factor. Magn Reson Med 36:61\u201365","journal-title":"Magn Reson Med"},{"key":"9352_CR48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/0748233793009001-214","volume":"9","author":"RA Floyd","year":"1993","unstructured":"Floyd RA, Carney JM (1993) The role of metal ions in oxidative processes and aging. Toxicol Ind Health 9:197\u2013214","journal-title":"Toxicol Ind Health"},{"key":"9352_CR49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000147312","volume":"144","author":"CM Morris","year":"1992","unstructured":"Morris CM, Candy JM, Oakley AE, Bloxham CA, Edwardson JA (1992) Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) 144:235\u2013257","journal-title":"Acta Anat (Basel)"},{"key":"9352_CR50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archpsyc.57.1.47","volume":"57","author":"G Bartzokis","year":"2000","unstructured":"Bartzokis G, Sultzer D, Cummings BJ, Holt LE, Hance DB, Henderson VW, Mintz J (2000) In vivo evaluation of brain iron in Alzheimer\u2019s disease and normal controls using magnetic resonance imaging. Arch Gen Psychiatry 57:47\u201353","journal-title":"Arch Gen Psychiatry"},{"key":"9352_CR51","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neurobiolaging.2006.02.005","volume":"28","author":"G Bartzokis","year":"2007","unstructured":"Bartzokis G, Tishler TA, Lu PH, Villablanca P, Altshuler LL, Carter M, Huang D, Edwards N, Mintz J (2007) Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 28:414\u2013423","journal-title":"Neurobiol Aging"},{"key":"9352_CR52","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/mrm.1910370409","volume":"37","author":"JW Bulte","year":"1997","unstructured":"Bulte JW, Miller GF, Vymazal J, Brooks RA, Frank JA (1997) Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths. Magn Reson Med 37:530\u2013536","journal-title":"Magn Reson Med"},{"key":"9352_CR53","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0730-725X(98)00155-6","volume":"17","author":"G Bartzokis","year":"1999","unstructured":"Bartzokis G, Cummings JL, Markham CH, Marmarelis PZ, Treciokas LJ, Tishler TA, Marder SR, Mintz J (1999) MRI evaluation of brain iron in earlier- and later-onset Parkinson\u2019s disease and normal subjects. Magn Reson Imaging 17:213\u2013222","journal-title":"Magn Reson Imaging"},{"key":"9352_CR54","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1474-4422(04)00809-9","volume":"3","author":"PM Doraiswamy","year":"2004","unstructured":"Doraiswamy PM, Finefrock AE (2004) Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol 3:431\u2013434","journal-title":"Lancet Neurol"},{"key":"9352_CR55","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(03)00353-3","volume":"2","author":"Y Ke","year":"2003","unstructured":"Ke Y, Ming Qian Z (2003) Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2:246\u2013253","journal-title":"Lancet Neurol"},{"key":"9352_CR56","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/cne.902910404","volume":"291","author":"AS Lamantia","year":"1990","unstructured":"Lamantia AS, Rakic P (1990) Cytological and quantitative characteristics of four cerebral commissures in the rhesus monkey. J Comp Neurol 291:520\u2013537","journal-title":"J Comp Neurol"},{"key":"9352_CR57","first-page":"3","volume-title":"Clinical neurology of aging","author":"T Kemper","year":"1994","unstructured":"Kemper T (1994) Neuroanatomical and neuropathological changes during aging and dementia. In: Albert M, Knoefel J (eds) Clinical neurology of aging 2nd edn. Oxford University Press, New York, pp 3\u201367","edition":"2nd edn"},{"key":"9352_CR58","first-page":"3","volume-title":"Regional development of the brain in early life","author":"PI Yakovlev","year":"1967","unstructured":"Yakovlev PI, Lecours AR (1967) Regional development of the brain in early life. Blackwell Scientific Publications, Boston, pp 3\u201370"},{"key":"9352_CR59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1471-4159.1958.tb12607.x","volume":"3","author":"B Hallgren","year":"1958","unstructured":"Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3:41\u201351","journal-title":"J Neurochem"},{"key":"9352_CR60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1214\/aoms\/1177731867","volume":"11","author":"H Hotelling","year":"1940","unstructured":"Hotelling H (1940) The selection of variates for use in prediction with some comments on the general problem of nuisance parameters. Ann Math Stat 11:271\u2013283","journal-title":"Ann Math Stat"},{"key":"9352_CR61","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1037\/0033-2909.87.2.245","volume":"87","author":"JH Steiger","year":"1980","unstructured":"Steiger JH (1980) Tests for comparing elements of a correlation matrix. Psychol Bull 87:245\u2013251","journal-title":"Psychol Bull"},{"key":"9352_CR62","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1073\/pnas.79.13.4217","volume":"79","author":"BK Hartman","year":"1982","unstructured":"Hartman BK, Agrawal HC, Agrawal D, Kalmbach S (1982) Development and maturation of central nervous system myelin: comparison of immunohistochemical localization of proteolipid protein and basic protein in myelin and oligodendrocytes. Proc Natl Acad Sci USA 79:4217\u20134220","journal-title":"Proc Natl Acad Sci USA"},{"key":"9352_CR63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00967665","volume":"9","author":"JL Trotter","year":"1984","unstructured":"Trotter JL, Wegescheide CL, Garvey WF (1984) Regional studies of myelin proteins in human brain and spinal cord. Neurochem Res 9:133\u2013146","journal-title":"Neurochem Res"},{"key":"9352_CR64","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1471-4159.1985.tb04024.x","volume":"45","author":"VS Schwob","year":"1985","unstructured":"Schwob VS, Clark HB, Agrawal D, Agrawal HC (1985) Electron microscopic immunocytochemical localization of myelin proteolipid protein and myelin basic protein to oligodendrocytes in rat brain during myelination. J Neurochem 45:559\u2013571","journal-title":"J Neurochem"},{"key":"9352_CR65","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/jnr.20181","volume":"77","author":"RJ Tolwani","year":"2004","unstructured":"Tolwani RJ, Cosgaya JM, Varma S, Jacob R, Kuo LE, Shooter EM (2004) BDNF overexpression produces a long-term increase in myelin formation in the peripheral nervous system. J Neurosci Res 77:662\u2013669","journal-title":"J Neurosci Res"},{"key":"9352_CR66","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000072261","volume":"25","author":"Y Du","year":"2003","unstructured":"Du Y, Fischer TZ, Lee LN, Lercher LD, Dreyfus CF (2003) Regionally specific effects of BDNF on oligodendrocytes. Dev Neurosci 25:116\u2013126","journal-title":"Dev Neurosci"},{"key":"9352_CR67","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1471-4159.2004.02911.x","volume":"92","author":"S Djalali","year":"2005","unstructured":"Djalali S, Holtje M, Grosse G, Rothe T, Stroh T, Grosse J, Deng DR, Hellweg R, Grantyn R, Hortnagl H, Ahnert-Hilger G (2005) Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development. J Neurochem 92:616\u2013627","journal-title":"J Neurochem"},{"key":"9352_CR68","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP, De Mey J, MacDonald ME, Lessmann V, Humbert S, Saudou F (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127\u2013138","journal-title":"Cell"},{"key":"9352_CR69","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","volume":"24","author":"JM Canals","year":"2004","unstructured":"Canals JM, Pineda JR, Torres-Peraza JF, Bosch M, Martin-Ibanez R, Munoz MT, Mengod G, Ernfors P, Alberch J (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington\u2019s disease. J Neurosci 24:7727\u20137739","journal-title":"J Neurosci"},{"key":"9352_CR70","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cne.902100309","volume":"210","author":"J O\u2019Kusky","year":"1982","unstructured":"O\u2019Kusky J, Colonnier M (1982) Postnatal changes in the number of astrocytes, oligodendrocytes, and microglia in the visual cortex (area 17) of the macaque monkey: a stereological analysis in normal and monocularly deprived animals. J Comp Neurol 210:307\u2013315","journal-title":"J Comp Neurol"},{"key":"9352_CR71","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neurobiolaging.2003.08.001","volume":"25","author":"G Bartzokis","year":"2004","unstructured":"Bartzokis G (2004) Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatric disorders. Neurobiol Aging 25:49\u201362","journal-title":"Neurobiol Aging"},{"key":"9352_CR72","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jnr.490260415","volume":"26","author":"SM LeVine","year":"1990","unstructured":"LeVine SM, Macklin WB (1990) Iron-enriched oligodendrocytes: a reexamination of their spatial distribution. J Neurosci Res 26:508\u2013512","journal-title":"J Neurosci Res"},{"key":"9352_CR73","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jsb.2005.11.001","volume":"153","author":"C Quintana","year":"2006","unstructured":"Quintana C, Bellefqih S, Laval JY, Guerquin-Kern JL, Wu TD, Avila J, Ferrer I, Arranz R, Patino C (2006) Study of the localization of iron, ferritin, and hemosiderin in Alzheimer\u2019s disease hippocampus by analytical microscopy at the subcellular level. J Struct Biol 153:42\u201354","journal-title":"J Struct Biol"},{"issue":"Suppl 1","key":"9352_CR74","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0022-510X(95)00207-I","volume":"134","author":"AJ Dwork","year":"1995","unstructured":"Dwork AJ (1995) Effects of diet and development upon the uptake and distribution of cerebral iron. J Neurol Sci 134(Suppl 1):45\u201351","journal-title":"J Neurol Sci"},{"key":"9352_CR75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7","volume":"17","author":"JR Connor","year":"1996","unstructured":"Connor JR, Menzies SL (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17:83\u201393","journal-title":"Glia"},{"key":"9352_CR76","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0165-3806(96)00020-X","volume":"93","author":"GL Erb","year":"1996","unstructured":"Erb GL, Osterbur DL, LeVine SM (1996) The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry. Brain Res Dev Brain Res 93:120\u2013128","journal-title":"Brain Res Dev Brain Res"},{"key":"9352_CR77","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0306-4522(84)90046-0","volume":"11","author":"JM Hill","year":"1984","unstructured":"Hill JM, Switzer RC (1984) The regional distribution and cellular localization of iron in the rat brain. Neuroscience 11:595\u2013603","journal-title":"Neuroscience"},{"key":"9352_CR78","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","volume":"60","author":"E Sapp","year":"2001","unstructured":"Sapp E, Kegel KB, Aronin N, Hashikawa T, Uchiyama Y, Tohyama K, Bhide PG, Vonsattel JP, DiFiglia M (2001) Early and progressive accumulation of reactive microglia in the Huntington disease brain. J Neuropathol Exp Neurol 60:161\u2013172","journal-title":"J Neuropathol Exp Neurol"},{"key":"9352_CR79","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","volume":"66","author":"N Pavese","year":"2006","unstructured":"Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA, Brooks DJ, Piccini P (2006) Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66:1638\u20131643","journal-title":"Neurology"},{"key":"9352_CR80","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bbamcr.2006.04.012","volume":"1763","author":"J Mehlhase","year":"2006","unstructured":"Mehlhase J, Gieche J, Widmer R, Grune T (2006) Ferritin levels in microglia depend upon activation: modulation by reactive oxygen species. Biochim Biophys Acta 1763:854\u2013859","journal-title":"Biochim Biophys Acta"},{"key":"9352_CR81","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/glia.20416","volume":"54","author":"X Zhang","year":"2006","unstructured":"Zhang X, Surguladze N, Slagle-Webb B, Cozzi A, Connor JR (2006) Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 54:795\u2013804","journal-title":"Glia"},{"key":"9352_CR82","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/cne.902100307","volume":"210","author":"J O\u2019Kusky","year":"1982","unstructured":"O\u2019Kusky J, Colonnier M (1982) A laminar analysis of the number of neurons, glia, and synapses in the visual cortex (area 17) of adult macaque monkeys. J Comp Neurol 210:278\u2013290","journal-title":"J Comp Neurol"},{"key":"9352_CR83","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/archpsyc.58.5.461","volume":"58","author":"G Bartzokis","year":"2001","unstructured":"Bartzokis G, Beckson M, Lu PH, Nuechterlein KH, Edwards N, Mintz J (2001) Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry 58:461\u2013465","journal-title":"Arch Gen Psychiatry"},{"key":"9352_CR84","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0893-133X(02)00364-0","volume":"27","author":"G Bartzokis","year":"2002","unstructured":"Bartzokis G (2002) Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacology 27:672\u2013683","journal-title":"Neuropsychopharmacology"},{"key":"9352_CR85","first-page":"55","volume":"29","author":"G Bartzokis","year":"2005","unstructured":"Bartzokis G (2005) Brain myelination in prevalent neuropsychiatric developmental disorders: primary and comorbid addiction. Adolesc Psychiatry 29:55\u201396","journal-title":"Adolesc Psychiatry"},{"key":"9352_CR86","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"9352_CR87","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","volume":"337","author":"DR Crapper McLachlan","year":"1991","unstructured":"Crapper McLachlan DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, Andrews DF (1991) Intramuscular desferrioxamine in patients with Alzheimer\u2019s disease [published erratum appears in Lancet 1991 Jun 29;337(8757):1618] [see comments]. Lancet 337:1304\u20131308","journal-title":"Lancet"},{"key":"9352_CR88","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","volume":"60","author":"CW Ritchie","year":"2003","unstructured":"Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li QX, Tammer A, Carrington D, Mavros C, Volitakis I, Xilinas M, Ames D, Davis S, Beyreuther K, Tanzi RE, Masters CL (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60:1685\u20131691","journal-title":"Arch Neurol"},{"key":"9352_CR89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0006-8993(02)03893-3","volume":"961","author":"RW Shin","year":"2003","unstructured":"Shin RW, Kruck TP, Murayama H, Kitamoto T (2003) A novel trivalent cation chelator feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer\u2019s disease. Brain Res 961:139\u2013146","journal-title":"Brain Res"},{"key":"9352_CR90","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","volume":"37","author":"D Kaur","year":"2003","unstructured":"Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, Boonplueang R, Viswanath V, Jacobs R, Yang L, Beal MF, DiMonte D, Volitaskis I, Ellerby L, Cherny RA, Bush AI, Andersen JK (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson\u2019s disease. Neuron 37:899\u2013909","journal-title":"Neuron"},{"key":"9352_CR91","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1073\/pnas.0502177102","volume":"102","author":"T Nguyen","year":"2005","unstructured":"Nguyen T, Hamby A, Massa SM (2005) Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington\u2019s disease mouse model. Proc Natl Acad Sci USA 102:11840\u201311845","journal-title":"Proc Natl Acad Sci USA"},{"key":"9352_CR92","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/S0024-3205(02)02135-5","volume":"71","author":"MB Newman","year":"2002","unstructured":"Newman MB, Arendash GW, Shytle RD, Bickford PC, Tighe T, Sanberg PR (2002) Nicotine\u2019s oxidative and antioxidant properties in CNS. Life Sci 71:2807\u20132820","journal-title":"Life Sci"},{"key":"9352_CR93","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1046\/j.1532-5415.2003.51368.x","volume":"51","author":"AE Finefrock","year":"2003","unstructured":"Finefrock AE, Bush AI, Doraiswamy PM (2003) Current status of metals as therapeutic targets in Alzheimer\u2019s disease. J Am Geriatr Soc 51:1143\u20131148","journal-title":"J Am Geriatr Soc"},{"key":"9352_CR94","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nn1460","volume":"8","author":"S Mi","year":"2005","unstructured":"Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill GLevesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB (2005) LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 8:745\u2013751","journal-title":"Nat Neurosci"},{"key":"9352_CR95","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1196\/annals.1306.025","volume":"1012","author":"MB Youdim","year":"2004","unstructured":"Youdim MB, Stephenson G, Ben Shachar D (2004) Ironing iron out in Parkinson\u2019s disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann NY Acad Sci 1012:306\u2013325","journal-title":"Ann NY Acad Sci"},{"key":"9352_CR96","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.3233\/JAD-2004-6S604","volume":"6","author":"G Bartzokis","year":"2004","unstructured":"Bartzokis G, Lu PH, Mintz J (2004) Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer\u2019s disease. J Alzheimers Dis 6:S53\u2013S59","journal-title":"J Alzheimers Dis"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-007-9352-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-007-9352-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-007-9352-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T14:53:48Z","timestamp":1587480828000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-007-9352-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,5]]},"references-count":96,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,9,17]]}},"alternative-id":["9352"],"URL":"https:\/\/doi.org\/10.1007\/s11064-007-9352-7","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,5]]}}}